Salvatore Iervolino

Author PubWeight™ 24.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early psoriatic arthritis: the clinical spectrum. J Rheumatol 2007 1.79
2 Platelet reactivity and disease activity in subjects with psoriatic arthritis. J Rheumatol 2011 1.51
3 Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis 2013 1.07
4 Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res (Hoboken) 2013 1.05
5 Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol 2011 1.02
6 Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 2006 1.00
7 Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. Clin Rheumatol 2010 0.97
8 Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford) 2012 0.96
9 The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol 2007 0.94
10 Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers. J Rheumatol 2012 0.91
11 Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther 2012 0.90
12 Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol 2013 0.87
13 Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 2012 0.86
14 Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Arthritis Care Res (Hoboken) 2012 0.85
15 Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies. Clin Rheumatol 2013 0.85
16 Alcohol dosing and the heart: updating clinical evidence. Semin Thromb Hemost 2011 0.84
17 Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol 2011 0.82
18 Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol 2014 0.82
19 Ultrasonography of peripheral entheses in the diagnosis and understanding of diffuse idiopathic skeletal hyperostosis (DISH). Rheumatol Int 2014 0.82
20 Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies. Ann Med 2014 0.81
21 TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis. Intern Emerg Med 2011 0.81
22 Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments. J Rheumatol 2014 0.80
23 Discovertebral erosions in patients with enteropathic spondyloarthritis. J Rheumatol 2012 0.78
24 Magnetic resonance imaging of nail unit in psoriatic arthritis. J Rheumatol Suppl 2009 0.78
25 Early psoriatic arthritis. J Rheumatol Suppl 2009 0.76
26 Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. J Clin Rheumatol 2011 0.75
27 A rare case of acute compartment syndrome after saphenectomy. World J Clin Cases 2013 0.75
28 Effectiveness of a rehabilitative programme in improving fatigue and function in rheumatoid arthritis patients treated with biologics: a pilot study. Clin Exp Rheumatol 2013 0.75
29 Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis. Clin Rheumatol 2011 0.75